Please assess the completion status of the following clinical trial:

Trial Title: Effects of Lutein on Visual Function

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Men and women age 40-60 years~* Corrected Visual Acuity of 20/20 to 20/25~* MPOD 0.05- 0.30 OD units~* Must be able to give written informed consent in English~* BMI \< or = 30 kg/m2~* Subject is willing to maintain a habitual diet and physical activity patterns throughout the study period~Exclusion Criteria:~* Use of carotenoid, fish oil, or n-3 fatty acid supplements (within 2 months of study start)~* Ocular pathologies~* History of active small bowel disease or resection~* Uncontrolled hypertension~* Diabetes mellitus~* Pancreatic disease~* Pregnancy (or planning to become pregnant) or lactation~* Diseases that interfere with fat absorption~* Medication or supplements that contain a significant level of carotenoids~* Medications that interfere with fat absorption~* Use of drugs suspected of interfering with metabolism of blood clotting~* Chronic alcohol intake~* Stroke, head injury with loss of consciousness or seizures~* Severe Amblyopia resulting in visual acuity worse than 0.4 MAR~* Subject is a heavy smoker (\> 1 pack/day)~* A regular consumer of lutein rich foods or lutein supplements~* A regular consumer of foods high in DHA intake or DHA supplements~* Subject has donated more than 300 mL of blood during the last three months prior to screening

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): Will be identical looking to treatment
- Lutein (Type: EXPERIMENTAL): 10 mg of FloraGLO Lutein

Based on this trial design, predict the completion outcome and termination type (if applicable).